Pediatric Cancers | Topics

 
Gwendolyn P. Quinn, PhD, on Sexual Health in AYA Cancer Survivors
January 08, 2021

“As the number of AYA survivors continues to grow, there is a pressing need for targeted information, education, and intervention around sexual health, intimate relationships, and body image,” the Children’s Oncology Group (COG) AYA Oncology Discipline Committee wrote in a review.

Jackelyn B. Payne, MPH, MA, on Fertility Preservation in AYAs with Cancer
December 15, 2020

Payne and colleagues indicated that a significant number of adolescent and young adult women are still not being given the information they desire regarding fertility preservation and therefore are not making fully informed treatment decisions.

FDA Grants Accelerated Approval to Naxitamab-gqgk Combo for the Treatment of Neuroblastoma
November 30, 2020

The FDA granted accelerated approval to naxitamab-gqgk (Danyelza) in combination with GM-CSF for the treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.